CMTX BIOTECH
CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients. It is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of its drug candidate in hospitalized COVID-19 patients. The company was founded in 2019 and is headquartered in Stony Brook, New York.
CMTX BIOTECH
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Stony Brook, New York, United States
Country:
United States
Website Url:
http://www.cmtxbiotech.com
Total Employee:
1+
Status:
Active
Contact:
631 258 5680
Email Addresses:
[email protected]
Current Employees Featured
Founder
Official Site Inspections
http://www.cmtxbiotech.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CMTx Biotech"
CMTx Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 631 258 5680 CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule …See details»
CMTX BIOTECH, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CMTX BIOTECH, INC. of Kings Park, NY. Get the latest business insights from Dun & Bradstreet.See details»
CMTx Biotech Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for CMTx Biotech. Use the PitchBook Platform to explore the full profile.See details»
CMTx Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore CMTx Biotech, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
CMTx Biotech, Inc. | LinkedIn
CMTx Biotech, Inc. Biotechnology Stony Brook, New York 1,394 followers Commercializing proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations.See details»
CMTx Biotech, Inc.: Contact Details and Business Profile
CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of …See details»
CMTx Biotech - Products, Competitors, Financials, Employees ...
Cmtxbiotech.com. Overview & Products; Financials; People; Founded Year 2019. Stage Other Investors | Alive. About CMTx Biotech. CMTx Biotech focuses on developing small molecule …See details»
CMTx Biotech - Overview, News & Similar companies - ZoomInfo
View CMTx Biotech (www.cmtxbiotech.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
CMTx Biotech - Org Chart, Teams, Culture & Jobs - The Org
CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory …See details»
CMTx Biotech, Inc. | VentureRadar
Similar Companies: Can-Fite Israel Privately Held Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a …See details»
CMTx Biotech Executes Exclusive License Agreement with Galderma
Kings Park, NY; March 15, 2021: CMTx Biotech announced today that it has executed an exclusive, worldwide license agreement to develop and commercialize incyclinide, a clinical …See details»
CMTx Biotech
CMTx Biotech is focused on developing innovative therapies for rare and pandemic diseases. Their research centers around the repurposing of chemically-modified tetracycline (CMT) …See details»
CMTx Biotech Inc. - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. CMTx Biotech Inc. - BIO …See details»
CMTx Biotech Submits pre-IND Meeting Request and Briefing
Kings Park, NY; May 18, 2021: CMTx Biotech announced today that it has submitted a pre-IND Meeting Request and Briefing Document to the U.S. Food and Drug Administration (FDA), …See details»
Clarametyx raises $33M to develop non-antibiotic CF treatment
Jan 8, 2024 Phase 1b/2a trial to test CF treatment candidate CMTX-101 in 41 adults. CF is caused by mutations in the CFTR gene, resulting in the abnormal accumulation of thick and …See details»
CMTx Biotech, Inc. Receives $315,000 NCATS Grant
CMTx Biotech announced today that it has received a $315,000 Clinical Trial Planning Grant from the National Center for Advancing Translational Sciences (NCATS), one of the 27 Institutes …See details»
Publications - CMTx Biotech, Inc.
Abstract Excerpt: Kaposi's sarcoma (KS) is an angioproliferative lesion that may regress or progress. Progression is related to spindle cell proliferation and the expression of human …See details»
Newsroom - CMTx Biotech, Inc.
Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic DiseasesSee details»
CMTx Biotech Shifting to Meet Pandemic Needs
CMTx Biotech is in the news today as one of a few Long Island companies refocusing their efforts to help fight the COVID-19 pandemic. CMTx Biotech is repurposing a clinical stage drug …See details»